Prolonged progestin treatment induces the promoter of CDK inhibitor p21 Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells. [electronic resource]
Producer: 20030616Description: 264-73 p. digitalISSN:- 0014-4827
- Breast Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases -- metabolism
- Cyclins -- drug effects
- Endometrial Neoplasms -- drug therapy
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Progestins -- pharmacology
- Promoter Regions, Genetic -- drug effects
- Response Elements -- drug effects
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.